Robotic pill maker Rani teams up with Chugai in deal worth up to $1.08B
Rani Therapeutics is pairing its oral delivery system with Chugai’s experimental rare disease antibody as part of a deal worth up to $1.08 billion. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
